Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lia Crotti

Showing results (231-240 of 246) with videos related to

Pageof 25
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.
European Heart Journal|August 2, 2023
Clinical presentation of calmodulin mutations: the International Calmodulinopathy RegistryLia Crotti, Carla Spazzolini, Mette Nyegaard, et al.
European Heart Journal|July 31, 2018
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroupsAlban-Elouen Baruteau, Florence Kyndt, Elijah R Behr, et al.
European Journal of Heart Failure|December 22, 2023
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy populationEdoardo Bertero, Chiara Chiti, Maria Alessandra Schiavo, et al.
Nature Genetics|July 23, 2013
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathConnie R Bezzina, Julien Barc, Yuka Mizusawa, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
Heart Rhythm|April 29, 2026
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variantsAlessio Gasperetti, Barbara Bauce, Alexandros Protonotarios, et al.
Circulation|January 17, 2020
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic ConditionJason D Roberts, S Yukiko Asaki, Andrea Mazzanti, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
European Heart Journal|December 19, 2025
Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratificationKrystien V Lieve, Christian van der Werf, Dania Kallas, et al.
Pageof 25

Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.
European Heart Journal|August 2, 2023
Clinical presentation of calmodulin mutations: the International Calmodulinopathy RegistryLia Crotti, Carla Spazzolini, Mette Nyegaard, et al.
European Heart Journal|July 31, 2018
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroupsAlban-Elouen Baruteau, Florence Kyndt, Elijah R Behr, et al.
European Journal of Heart Failure|December 22, 2023
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy populationEdoardo Bertero, Chiara Chiti, Maria Alessandra Schiavo, et al.
Nature Genetics|July 23, 2013
Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac deathConnie R Bezzina, Julien Barc, Yuka Mizusawa, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
Heart Rhythm|April 29, 2026
External validation of the DSP-Risk Score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy associated genetic variantsAlessio Gasperetti, Barbara Bauce, Alexandros Protonotarios, et al.
Circulation|January 17, 2020
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic ConditionJason D Roberts, S Yukiko Asaki, Andrea Mazzanti, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
European Heart Journal|December 19, 2025
Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratificationKrystien V Lieve, Christian van der Werf, Dania Kallas, et al.
Pageof 25